## IVZ: Invesco Ltd. - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 0.46 indicates fundamental undervaluation. Consistent execution (3/4 quarters beat estimates). Caution: declining volume (50% of avg), momentum weakening (-3.4% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($25.18)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Invesco SteelPath MLP Alpha Fund Q3 2025 Commentary (Mutual Fund:MLPAX)**
- Source: Seeking Alpha | 20251230T120812 | Somewhat-Bullish | Relevance: 100%
- The Invesco SteelPath MLP Alpha Fund's Q3 2025 commentary highlights that Master Limited Partnerships (MLPs) underperformed the broader equity market, with the Alerian MLP Index losing 3.04% on a price basis. Despite this, the midstream sector saw 62% of participants report strong Q2 results, attributed to attractive valuations leading to stock buybacks and increasing natural gas demand from AI data centers. The fund believes the midstream sector offers attractive distribution yields and improving cash flow and distribution growth prospects.

**2. Invesco QQQ $QQQ is Encompass More Asset Management's 5th Largest Position**
- Source: MarketBeat | 20251229T101945 | Neutral | Relevance: 97%
- Encompass More Asset Management recently reduced its stake in Invesco QQQ (NASDAQ:QQQ) by 14.2%, making it still their 5th largest position. Several other institutional investors have increased their holdings in the ETF, while the stock currently trades at $623.89 and has a 0.5% annualized dividend yield. The article also touches on mixed sentiment regarding QQQ's future, with positive views on tech ETFs for 2026 and negative sentiment concerning potential valuation risks and market rotation to value stocks.

**3. First Trust Senior Floating Rate Income Fund II (NYSE:FCT) Sees Significant Decrease in Short Interest**
- Source: Defense World | 20251228T140932 | Somewhat-Bullish | Relevance: 65%
- First Trust Senior Floating Rate Income Fund II (NYSE:FCT) experienced a significant 34.7% decrease in short interest in December, falling to 49,124 shares by December 15th. This change, coupled with a high average daily trading volume, results in a low short-interest ratio of 0.2 days. Several institutional investors also modified their holdings in FCT during the third quarter, with some significantly increasing their stakes.

**4. Apella Capital LLC Makes New $811,000 Investment in Invesco BulletShares 2031 Corporate Bond ETF $BSCV**
- Source: Defense World | 20251230T080950 | Neutral | Relevance: 65%
- Apella Capital LLC has made a new $811,000 investment in the Invesco BulletShares 2031 Corporate Bond ETF ($BSCV), acquiring 48,234 shares. This strategic move makes Apella Capital LLC an approximate 0.06% owner of the ETF. Other institutional investors have also adjusted their holdings in BSCV, and the fund recently declared a monthly dividend.

**5. Armbruster Capital Management Inc. Boosts Stake in Invesco S&P SmallCap Low Volatility ETF $XSLV**
- Source: Defense World | 20251230T090844 | Neutral | Relevance: 64%
- Armbruster Capital Management Inc. increased its holdings in the Invesco S&P SmallCap Low Volatility ETF (XSLV) by 6.4% in the third quarter, making it their 15th biggest holding. The firm now owns 237,575 shares valued at $11,002,000. Other institutional investors like Laurel Wealth Advisors LLC, Jane Street Group LLC, and Invesco Ltd. also adjusted their stakes in XSLV.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 4, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $28 | $27 | +4% |
| 2025-12-17 | Deutsche Bank | $31 | $26 | +19% |
| 2025-12-12 | Barclays | $28 | $25 | +12% |
| 2025-12-10 | BMO Capital | $30 | $28 | +7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Equal-Weight |
| 2025-12-17 | Deutsche Bank | up | Buy |
| 2025-12-12 | Barclays | main | Equal-Weight |
| 2025-12-10 | BMO Capital | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 4 ($2.25M) |
| Sells | 4 ($4.39M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 60.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 3 |

**Top Holders:**
- Massachusetts Mutual: 18.3% (0.0%)
- Vanguard Group Inc: 11.7% (+1.1%)
- Blackrock Inc.: 8.5% (-16.7%)
- State Street Corpora: 4.8% (-3.3%)
- Dimensional Fund Adv: 4.8% (+1.5%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-3.4% 5d) with bearish MACD, trend may be turning.
2. Insider selling cluster: $4.4M in recent transactions.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- Analyst target momentum: 4 raises (avg +11%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.46 indicates undervaluation relative to growth. Forward P/E 10.5x attractive for 27% earnings growth. Quality metrics strong (margin 17%). Analyst sentiment positive (4 raises, avg +11%). Institutional flow bullish (5 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.8B |
| Beta | 1.64 |
| 52W Range | $11.60 - $27.48 |
| Short Interest | 5.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.46 |
| Forward P/E | 10.5 |
| Current P/E | 13.4 |
| YoY Growth | 27.1% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 3.8% to 0.4% (-3.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.6pp (needs >4.0% for momentum thesis). MRS_5 (-1.2%) diverging from MRS_20 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 57. Volume at 50% of 20MA suggests lack of conviction. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.40% (CS: 54) | Neutral |
| RSI_14 | 56.9 | Neutral |
| MACD Histogram | -0.07 | Bearish |
| vs SMA20 | 1.005x | Above |
| vs SMA50 | 1.074x | Above |
| vs SMA200 | 1.348x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $26.46
- **Stop Loss:** $25.18 (4.8% risk)
- **Target:** $29.02 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 644
- **Position Value:** $17,040.24
- **Portfolio %:** 17.04%
- **Risk Dollars:** $825.00
- **Risk Per Trade:** 0.83%
- **Modifiers:** L1 110% | L2 75% | Combined 0.83x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-01-27 (Est: $0.57)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.44 | $0.61 | +37.7% |
| 2025Q2 | $0.40 | $0.36 | -10.7% |
| 2025Q1 | $0.39 | $0.44 | +13.9% |
| 2024Q4 | $0.47 | $0.52 | +9.6% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*